# Clinical Protocol for Convalescent Plasma and Remdesivir Therapy in Nepal

> **NCT04570982** · — · UNKNOWN · sponsor: **Dr. Pradip Gyanwali,MD** · enrollment: 200 (estimated)

## Conditions studied

- COVID-19

## Interventions

- **BIOLOGICAL:** Convalescent Plasma

## Key facts

- **NCT ID:** NCT04570982
- **Lead sponsor:** Dr. Pradip Gyanwali,MD
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-07-30
- **Primary completion:** 2020-10-30
- **Final completion:** 2020-12-30
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2020-09-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04570982

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04570982, "Clinical Protocol for Convalescent Plasma and Remdesivir Therapy in Nepal". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04570982. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*